Civilization Ventures
Civilization Ventures is a venture capital firm focused on investing in scientific founders who are pioneering cutting-edge innovations in health tech and biology. The firm emphasizes a founder-centric approach, providing mentorship and support to help entrepreneurs reach their full potential. With a mission to back disruptive innovations that advance human longevity, Civilization Ventures manages over $100 million in capital and has partnered with more than 60 innovative companies. Their investment focus includes genomics, diagnostics, digital health, and synthetic biology.
Industries
N/A
Nr. of Employees
small (1-50)
Portfolio
Rocket Pharma has multiple first-in-class gene therapies in clinical trials to cure devastating inherited diseases.
#Gene Therapy
Singular Bio was acquired to help increase access to accurate genetic screening in early pregnancy.
#Genetic Screening
Lemonaid Health was acquired in a landmark $400M acquisition by 23andme.
#Telemedicine
Rewrite was acquired for $200M, marking a key move in the gene editing industry.
#Gene Editing
Foresight Diagnostics focuses on ultrasensitive diagnostics to catch cancer earlier and save lives.
#Diagnostics
BillionToOne is revolutionizing prenatal disease detection and cancer diagnostics by catching one molecule in a few billion.
#Diagnostics
Rocket Pharma has multiple first-in-class gene therapies in clinical trials to cure devastating inherited diseases.
#Gene Therapy
Singular Bio was acquired to help increase access to accurate genetic screening in early pregnancy.
#Genetic Screening
Lemonaid Health was acquired in a landmark $400M acquisition by 23andme.
#Telemedicine
Rewrite was acquired for $200M, marking a key move in the gene editing industry.
#Gene Editing
Foresight Diagnostics focuses on ultrasensitive diagnostics to catch cancer earlier and save lives.
#Diagnostics
BillionToOne is revolutionizing prenatal disease detection and cancer diagnostics by catching one molecule in a few billion.
#Diagnostics